BioCentury
ARTICLE | Clinical News

Zorbtive somatropin recombinant human growth hormone regulatory update

December 8, 2003 8:00 AM UTC

The FDA granted marketing approval for Zorbtive to treat short bowel syndrome from SEO. Earlier this year, the FDA granted marketing approval for Serostim (Zorbtive) to treat HIV wasting or cachexia....